期刊文献+

着色性干皮病基因D Lys751Gln多态性与非霍奇金淋巴瘤临床表型及化疗疗效的相关性

Correlations between gene polymorphisms of xeroderma pigmentosum gene D Lys751Gln and clinical phenotypes and chemotherapeutic effects of non-Hodgkin's lymphoma
原文传递
导出
摘要 目的探讨着色性干皮病基因D(XPD)Lys751Gln多态性与非霍奇金淋巴瘤(NHL)临床表型及化疗疗效的相关性。方法收集87例广西NHL患者的外周血样本,检测XPD Lys751Gln位点的基因多态性,并分析各基因型与NHL临床表型及化疗疗效的相关性。结果①XPD Lys751Gln(T>G)多态性位点在87例NHL患者中的基因型频数分布为:T/T基因型71例(81.6%),T/G基因型16例(18.4%),未发现G/G基因型;②T/T及T/G基因型的频率在不同NHL细胞来源组、不同肿瘤恶性程度组、有无B症状组、不同国际预后指数组分布均无统计学差异(P>0.05);③T/T及T/G基因型的频率在化疗有效与无效患者之间的分布无统计学差异(P>0.05)。结论在中国广西NHL患者中,XPD基因Lys751Gln多态性与NHL不同临床表型(细胞来源、肿瘤恶性程度、有无B症状、危险程度)及化疗疗效均无统计学相关性。 Objective To explore the correlations between gene polymorphisms of xeroderma pigmentosum gene D (XPD) Lys751Gln and different clinical phenotypes and chemotherapeutic effects of non-Hodgkin' s lymphoma (NHL). Methods Peripheral blood samples of 87 NHL patients from Guangxi of China were collected. The gene pol- ymorphism of XPD Lys751Gln was detected, and the correlations between different gene types, NHL clinical pheno- types and chemotherapeutic effects were analyzed. Results (~) Among 87 NHL patients, T/T and T/G genotypes of XPD Lys751 Gln( T 〉 G) polymorphism sites were found in 71 cases ( 81.6 % ) and 16 cases ( 18.4 % ) respectively, but G/G genotype was not found. (~) TT and TG genotype frequencies of XPD Lys751Gln showed no significant differ- ences in the distributions of different NHL cell source groups, different malignant degree groups, with/without B symptom groups and different international prognostic index (IPI) groups (P 〉 0.05 ). (3) The distributions of TT and TG genotype frequencies between NHL patients with/without chemotherapeutic effects had no significant differences ( P 〉 0.05 ). Conclusion Among NHL patients from Guangxi of China, there are no conspicuous associations between the XPD Lys751 Gin polymorphism and different clinical phenotypes ( cell source, malignant degree of tumors, with/ without B symptom and dangerous degrees) and response to chemotherapy.
出处 《山东大学学报(医学版)》 CAS 北大核心 2013年第4期62-66,共5页 Journal of Shandong University:Health Sciences
基金 广西科学基金资助项目(桂科基0342010-7)
关键词 非霍奇金淋巴瘤 基因 着色性干皮病 单核苷酸多态性 Non-Hodgkin' s lymphomas Gene Xeroderma pigmentosum Single nucleotide polymorphism
  • 相关文献

参考文献18

  • 1Mfiller A M, Ihorst G, Mertelsmann R, et al. Epidemiol- ogy of non-Hodgkin' s lymphoma (NHL) : trends, geo- graphic distribution, and etiology [ J]. Ann Hematol, 2005, 84(1) :1-12. 被引量:1
  • 2Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis [ J]. Int J Med Sci, 2007, 4 (2) :59-71. 被引量:1
  • 3Batar B, Guven M, Baris S, et al. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood a- cute lymphoblastic leukemia [ J]. Leuk Res, 2009, 33 (6) :759-763. 被引量:1
  • 4Papaefthymiou M A, Giaginis C T, Theocharis S E, et al. DNA repair alterations in common pediatric malignan- cies[ J]. Med Sci Mont, 2008, 14(3) :8-15. 被引量:1
  • 5Manuguerra M, Saletta F, Karagas M R, et al. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review[ J]. Am J Epidemiol, 2006, 16(4) :297-302. 被引量:1
  • 6Hoeijmakers J H. Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associ- ated diseases[ J] Mech Ageing Dev, 2007, 128(7-8): 460-462. 被引量:1
  • 7Baris S, Celkan T, Batar B, et al. Association between genetic polymorphism in DNA repair genes and risk of B- cell lymphoma[ J] Pediatr Hematol Oncol, 2009, 26 (6) :467-472. 被引量:1
  • 8Shi J Y, Ren Z H, Jiao B, et al. Genetic variations of DNA repair genes and their prognostic significance in pa- tients with acute myeloid leukemia E J ]. Int J Cancer, 2011, 128(1) :233-238. 被引量:1
  • 9刘新,李颖,徐功立,许洪志.Survivin在非霍奇金淋巴瘤中的表达及意义[J].山东大学学报(医学版),2007,45(3):283-285. 被引量:2
  • 10Kuptsova N, Kopecky K J, Godwin J. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials E J ]. Blood, 2007, 109(9) :3936-3944. 被引量:1

二级参考文献24

  • 1Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma[J].Nat Med,1997,3(8):917-921. 被引量:1
  • 2Sarela AI,Macadam RC.Expression of the anti-apoptosis gene,survivin,predicts death from recurrent colorectal carcinoma[J].Gut,2000,46(5):645-650. 被引量:1
  • 3Ashraful I,Jajime K,Nalyuki T,et al.High expression of survivin,mapped to 17q25,is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma[J].Oncogene,2000,19(5):617-623. 被引量:1
  • 4konno R,yamakawa H,Utsunomiya H,et al.Expression of survivin and bcl-2 in the normal human endometrium[J].Mol Hum Report,2000,6(6):529-534. 被引量:1
  • 5Escuin D,Rosell R.The anti-apoptosis survivin gene and its role in human cancer:an overview[J].Clin Lung Cancer,1999,1(2):138-143. 被引量:1
  • 6Altieri DC.Survivin,versatile modulation of cell division and apoptosis in cancer[J].Oncogene,2003,22(53):8 581-8 589. 被引量:1
  • 7Morra E.The biological market of non-Hodgkin's lymphomas:their role in diagnosis,prognostic assessment and the rapeutic strategy[J].Int J Biol Markets,1999,14(3):149-153. 被引量:1
  • 8Adida C,Haioun C,Gaulard P,et al.Prognostic significance of survivin expression in diffuse large B-cell lymphoma[J].Blood,2000,96(5):1 921-1 925. 被引量:1
  • 9Martinez A,Bellosillo B,Bosch F,et al.Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival[J].Am J Pathol,2004,164(2):501-510. 被引量:1
  • 10Schlette EJ,Medeiros LJ,Goy A,et al.Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma[J].J Clin Oncol,2004,22(9):1 682-1 688. 被引量:1

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部